CD2AP and Alzheimer disease: Furthermore, the migration of peripheral immune cells to the brain parenchyma through a compromised blood–brain barrier, a phenomenon that is observed in AD, may be linked to CD2AP: CD2AP stabilizes cell–cell adherens junctions [74, 99] and increased blood–brain-barrier permeability is observed in CD2AP knockout mice [100].